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Cellular uptakea b s t r a c t
Glycosaminoglycans (GAGs) contribute to the cellular uptake of cationic cell-penetrating peptides
(CPPs). However, molecular details about the contributions of GAGs in CPP internalization remain
unclear. In this study, we examined the cellular uptake mechanism of the arginine-rich CPP pitui-
tary adenylate-cyclase-activating polypeptide (PACAP). We observed that the uptake efﬁcacy of
PACAP is dependent on the expression of cell surface GAGs. As the binding of PACAP to sulfated GAGs
induced a random coil-to-a-helix conformational conversion, we investigated the role of the helical
formation in PACAP internalization. Whereas this secondary structure was not crucial for efﬁcient
internalization in GAGs-deﬁcient cells, PACAP a-helix was essential for GAGs-dependent uptake.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Over the last two decades, cell-penetrating peptides (CPPs) have
gained increase of interest as chemical tools for the intracellular
delivery of macromolecular cargoes intended for biological and
medical applications [1]. CPPs are a class of diverse peptides, usu-
ally ranging from 5 to 30 residues, which can cross the plasma
membrane through a variety of mechanisms that remain partially
elusive. According to their physicochemical properties, CPPs can be
classiﬁed into three major classes: (i) cationic, (ii) amphipathic and
(iii) hydrophobic [2]. Cationic CPPs are short peptides that are rich
in arginine and lysine residues [3,4]. The vast majority of CPPs
derived from natural protein motifs and were identiﬁed in DNA/
RNA-binding proteins, viral proteins, signal peptides or heparin-
binding proteins [2]. Interestingly, we recently reported that an
endogenous peptide neurohormone, pituitary adenylate cyclase-
activating polypeptide (PACAP), can cross efﬁciently the plasmamembrane in a speciﬁc receptor-independent manner, mainly by
active endocytosis involving clathrin-dependent pathway and
micropinocytosis [5]. This peptide was highly effective to mediate
the uptake of a variety of cargoes, including protein and DNA plas-
mid [6]. The cellular uptake efﬁcacy of PACAP was 3 times as high
as that observed for the TAT peptide [5], underlining the potent
ability of this peptide to cross plasma membrane. These studies
have identiﬁed PACAP as a new member of the CPP family and
suggest that PACAP derivatives represent excellent vectors for
the intracellular delivery of non-permeable (bio)molecules. None-
theless, as for other CPPs, the elucidation of the molecular require-
ments of PACAP internalization is necessary to improve its delivery
efﬁciency.
PACAP is a 38-amino acid C-terminally-a-amidated peptide
that encompasses 11 basic residues, i.e. 4 arginines and 7 lysines,
conferring a polycationic nature to this peptide (Fig. 1A) [7]. PACAP
exhibits a random coil conformation in aqueous solutions whereas
the central and C-terminal domains of the polypeptide chain read-
ily adopt a helical structure in membrane mimicking milieu, such
as dodecylphosphocholine (DPC) micelles (Fig. 1B) [8–10]. Helical
wheel representation of this putative helical segment shows that
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(Fig. 1C), conferring a highly positive charge distribution on the
overall surface of the peptide. For cationic CPPs, it has been
reported that membrane-associated glycosaminoglycans (GAGs)
contribute signiﬁcantly to their cellular uptake [11]. For instance,
the removal of cell surface sulfated GAGs was shown to decrease
substantially the cellular uptake of the TAT peptide [12], penetratin
[13,14] and the R8 poly-arginine peptide [15].
GAGs, including heparan sulfate (HS) and chondroitin sulfate
(CS), are long and linear polysaccharides composed of repeating
disaccharide units [16]. They are abundant on the outer leaﬂet of
the plasma membrane of every cell type of metazoan organisms
where they are O-linked to proteoglycans [17]. Owing to their high
content in carboxylate and sulfate groups, GAGs are highly nega-
tively charged biopolymers that surround cells. Despite the well-
recognized importance of GAGs in the uptake of cationic CPPs,
the molecular details regarding the roles of proteoglycans are still
a matter of controversy and several mechanisms have been
inferred from biophysical and biochemical investigations. It has
been recently proposed by Favretto et al. [11] that the roles of
GAGs in the endocytosis of CPPs could be ascribed to either (i)
GAGs clustering upon peptide binding, (ii) co-clustering of a
receptor and GAGs upon CPP binding and/or (iii) GAGs mediating
peptide adsorption to the plasma membrane. Particularly, in
contrast to amphipathic CPPs, the importance of the secondary
structure of cationic CPPs has been poorly investigated so far.
In this study, we ﬁrst investigated the roles of cell surface GAGs
in the adsorption of PACAP to the outer leaﬂet of plasma mem-
brane and its subsequent cellular uptake. Considering that the
binding of PACAP to sulfated GAGs induced a random coil-to-a-
helix conformational conversion, we studied the contribution of
this secondary structure in cellular uptake. This study highlights
the mechanistic elements of PACAP endocytosis and exposes a
new molecular basis of GAGs-mediated uptake of cationic CPPs.
2. Materials and methods
2.1. Peptide synthesis, puriﬁcation and characterization
Peptides were synthesized on solid phase, puriﬁed by reverse-
phase high performance liquid chromatography and characterized
by mass spectrometry as described in the Supplementary
Materials.
2.2. Peptide uptake
CHO-K1 and CHO-pgs-A-745 were seeded in 12-well plates at a
density of 30000 cells/well for 48 h. Cells were incubated inFig. 1. Sequence and structure of PACAP. (A) Primary structure of PACAP with basic
residues indicated in italic bold letters. (B) Schematic ribbon representation of
micelle-bound PACAP secondary structure (PDB code: 2D2P). (C) Helical wheel
representation of the putative a-helix segment of PACAP (Thr7-Lys38) with basic
residues indicated in blue.presence of ﬂuorescein-labeled peptides for 1 h at 37 C and 5%
CO2. Time of incubation was deﬁned according to our previous
study [5]. After incubation, cells were washed twice with HBSS
buffer, treated for 5 min with 100 lg/ml heparin to remove the
excess of peptide bound to the cell surface [18,19], washed once
again and detached by trypsinization. Trypsin action was stopped
and cells were centrifuged. Cells were resuspended in 500 ll
sorting buffer and kept on ice until ﬂow cytometry analysis. For
heparinase treatment, CHO-K1 cells were seeded as above-
described. After 24 h incubation, cells were treated overnight with
8 UI/ml of heparinase. One hour before cell treatment with peptide,
heparinase was added and experiments were performed as
above-described. These methods are described in details in Supple-
mentary Materials.
2.3. Membrane binding
Cell surface absorption was assessed using a protocol adapted
from Gump et al. [20]. Cells were seeded as above-described and
after 48 h, cells were incubated on ice at 4 C for 10 min. Cells were
then incubated in presence of ﬂuorescein-labeled peptide for
15 min at 4 C. Cells were then washed 3 times and detached man-
ually. Cells were centrifuged at 4 C before being resuspended in
sorting buffer. Flow cytometry analyses were performed using a
FACS Calibur instrument (BD Biosciences) and a minimum of
10000 gated cells per sample were analyzed. These methods are
described in details in Supplementary Materials.
2.4. Characterization of PACAP-sulfated GAGs interactions
Afﬁnity chromatography, circular dichroism (CD) spectroscopy
and static light scattering were used to probe PACAP interaction
with heparin as described in the Supplementary Materials.
3. Results
3.1. Cell surface glycosaminoglycans promote cellular uptake and
membrane binding of PACAP
According to the high positive net charge of PACAP, we initially
investigated the potential role of cell surface GAGs in the uptake
and membrane binding. We used the CHO-pgs-A-745 cells, which
are deﬁcient in xylosyltransferase, an enzyme that catalyzes the
transfer of a D-xylosyl group to the side chain of a serine, a key step
in the synthesis of proteoglycans. As a consequence, these cells do
not express any GAGs on their plasma membrane [21]. As observed
by ﬂow cytometry, pgs-A-745 cells were signiﬁcantly less effective
than their wild type counterpart to internalize ﬂuorescein-labeled
PACAP (Fig. 2A and B). To conﬁrm that these results were not a
consequence of a defect in the endocytosis machinery of CHO-
pgs-A-745, we exposed the CHO-K1 cells to an enzymatic treat-
ment to remove cell surface GAGs. To digest cell surface HS, two
successive treatments with 8 UI/ml heparinase I/III were per-
formed. Such treatment was previously shown to be effective for
decreasing the amount of cell surface GAGs, while not affecting
the integrity of the plasma membrane [22,23]. It is worth mention-
ing that HSPGs constitute the major proteoglycans of CHO-K1 cells
[24]. The uptake of PACAP was reduced by approximately 50%
upon HS enzymatic removal with heparinase (Fig. 2C and D). Par-
ticularly, CHO-K1 heparinase-treated cells showed a comparable
uptake of PACAP to pgs-A-745 cells. Secondly, we addressed the
contributions of proteoglycans in extracellular membrane
association by incubating the cells at 4 C for 15 min before detach-
ing them with a non-enzymatic treatment. Such conditions are
known to inhibit active endocytic pathways [14,20]. As observed
Fig. 2. Role of cell surface glycosaminoglycans in PACAP cellular uptake. (A) Representative ﬂow cytometry histograms showing cellular uptake of 1 lM PACAP in CHO-K1
(red) and CHO-pgs-A-745 (black) cells. (B) Cellular uptake of PACAP by CHO-K1 and CHO-pgs-A-745 cells. (C) Representative ﬂow cytometry histograms showing cellular
uptake of 1 lM PACAP in CHO-K1 cells treated with 8 UI/ml heparinase (black) and non-treated control cells (red). (D) Cellular uptake of PACAP by CHO-K1 treated or not with
8 UI/ml heparinase. (B, D) Data represent the relative mean ﬂuorescence intensity (±S.E.M.) of gated cells from at least 3 individual experiments and results are expressed as a
percentage of the median ﬂuorescence for 5 lM PACAP in CHO-K1 cells. (A–D) Cells were incubated for 1 h at 37 C in 5% CO2 with ﬂuorescein-PACAP, washed twice in HBSS,
treated with 100 lg/ml heparin for 5 min, detached by trypsin treatment, washed by centrifugation and resuspended in ice-cold sorting buffer before ﬂow cytometry analysis.
Fig. 3. Role of cell surface glycosaminoglycans in PACAP binding to the cell surface. (A) Representative ﬂow cytometry histograms showing membrane binding at 4 C of 1 lM
PACAP on CHO-K1 (red) and CHO-pgs-A-745 (black) cells. (B) Membrane binding at 4 C of PACAP on CHO-K1 and CHO-pgs-A-745 cells. Data represent the relative mean
ﬂuorescence intensity (±S.E.M.) of gated cells from at least 3 individual experiments and results are expressed as a percentage of the median ﬂuorescence for 5 lM PACAP38
in CHO-K1 cells. (A, B) Pre-chilled cells were incubated for 15 min at 4 C with ﬂuorescein-PACAP, washed 3 times with ice-cold HBSS, detached mechanically with a cell
scraper, washed by centrifugation at 4 C and resuspended in ice-cold sorting buffer before ﬂow cytometry analysis.
4592 A. Tchoumi Neree et al. / FEBS Letters 588 (2014) 4590–4596for endocytosis, the extent of cell membrane binding was depen-
dent on the presence of GAGs, with cell surface absorption being
approximatively 3-fold higher for CHO-K1 (Fig. 3A and B). These
results demonstrate the major contributions of cell surface GAGs
in PACAP cellular uptake and membrane binding. Nonetheless,
GAGs-independent mechanisms of endocytosis and membrane
absorption also contributed to some extent to internalization,
suggesting that sialic acid and/or anionic phospholipids could be
involved in PACAP attachment to the cell surface. This is in agree-
ment with previous studies reporting that the removal of cell sur-
face HS leads to a 20–80% reduction of uptake of cationic CPPs
[11,12,14,15].3.2. Conformational conversion of PACAP upon binding to heparin
PACAP exhibits mainly a random coil conformation in aqueous
solution while it readily adopts an a-helix in presence of DPC
micelles [25–27]. By CD spectroscopy, the far-UV spectra of PACAP
in absence of heparin exhibited a single minimum at 200 nm
characteristic of a random coil structure, although signals around
210–220 nm indicate a slight contribution of ordered secondary
structure (Fig. 4). In contrast, in presence of 12.5 and 50 lM hepa-
rin, CD spectra displayed two negative minima at 208 and 222 nm
and a positive maximum at 192 nm, indicative of a helical confor-
mation (Fig. 4). At 3.125 lM heparin, the CD signal was weak and
Fig. 4. Conformational conversion of PACAP upon binding to heparin. Circular
dichroism spectra of PACAP (50 lM) in absence or in presence of increasing
concentrations of heparin (3.125–50 lM). Buffer in all experiments is 20 mM
phosphate, 100 mM NaF, pH 7.4 and temperature was set at 25 C.
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duced by the formation of large particles that could be observed
by visual inspection. These data suggest that heparin acts as a
molecular anionic surface for the conformational conversion of
PACAP.
3.3. Role of conformational conversion in PACAP cellular uptake
This random coil-to-a-helix conformational conversion upon
PACAP binding to sulfated GAGs has been previously reported for
the cationic lytic peptide melittin [28] and for analogs of the CPP
penetratin [29]. However, the contribution of this structural
change in the uptake of cationic CPPs has not been addressed so
far. Thus, we investigated this issue by designing two PACAP
analogs in which two or three pairs of adjacent residues were
substituted with their corresponding D-enantiomers. Double D-
substitutions introduced in the putative helical region of PACAP
should result in disturbance of the a-helix, without modifying
other properties of the peptide such as hydrophobicity and net
charge [30]. Considering that the a-helix in structure-induced
milieu spans from Thr7 to the C-terminal end [10], we introduced
the D,D successive substitutions in positions 11–12 and 23–24
(D4-PACAP) as well as in positions 11–12, 23–24 and 33–34 (D6-
PACAP) to disrupt the formation of the a-helix induced by heparin.
By CD spectroscopy, D4-PACAP and D6-PACAP exhibited mainly a
random coil conformation in absence or in presence of heparin
with spectra exhibiting a single minimum ﬂuctuating between
200 and 205 nm (Fig. 5A and B). To conﬁrm that the incapacity of
D,D-residue containing analogs to switch into helical conformation
was not the result of a lower binding afﬁnity towards the sulfated
GAG, we initially performed afﬁnity chromatography. D4-PACAP
and D6-PACAP eluted from the heparin-Sepharose column approx-
imately at the same NaCl concentration as that of PACAP (Fig. 5C),
conﬁrming that these two derivatives bound heparin with a rela-
tively high afﬁnity.
As revealed by chromatography, D4-PACAP and D6-PACAP bind
to heparin to the same extent as PACAP although, as observed by
CD spectroscopy, this binding event is not accompanied with the
formation of a helical structure. Thus, the role of PACAP random
coil-to-a-helix conformational conversion in uptake was assessed
by evaluating the endocytosis of ﬂuorescein-labeled D,D deriva-
tives. D4-PACAP and D6-PACAP were signiﬁcantly less internalizedin CHO-K1 cells compared to PACAP with relative cellular uptakes
varying between 10% and 20% of that PACAP (Fig. 6A and B). In con-
trast, in GAGs-defective pgs-A-745 cells, the uptake efﬁcacies of
doubly D-substituted analogs were ranging between 60% and 80%
of that PACAP (Fig. 6C and D). The relative lower extent of uptake
of D,D-derivatives in CHO-K1, in contrast to pgs-A-745, indicates
that the a-helix structure is critical for GAGs-mediated endocytosis
whereas GAGs-independent internalization is less affected by the
locked random coil conformation of PACAP.
While trying to characterize the thermodynamics and binding
constants of the interaction of PACAP with sulfated GAGs by iso-
thermal titration calorimetry (ITC), an approach that we routinely
used [31], we were unsuccessful to get a clear calorimetry plot,
most likely because of a prompt aggregation event. In fact, we
could observed by visual inspection that the heparin solution
become turbid upon PACAP addition. It has been previously shown
that GAGs clustering plays a pivotal role in the endocytosis of cat-
ionic CPPs, such as WR9 [32] and penetratin [14]. Therefore, we
explored if the lower GAGs-dependent cellular uptake of D4-
PACAP and D6-PACAP could not be ascribed to a lower capacity
to cluster sulfated GAGs. First, we attempted to analyze by
dynamic light scattering the formation of molecular heparin–
peptide complexes, but this approach was not appropriate as hep-
arin–PACAP clusters aggregated too quickly and to large extent.
Consequently, reliable data could not be obtained. Hence, we
simply monitored the increase of solution turbidity at 400 nm
upon the titration of the peptide into heparin and vice versa. When
heparin (1.25 ll; 100 lM) was successively titrated into PACAP
solution (1 ml; 50 lM), we observed a rapid increase of turbidity
after an initial baseline during the ﬁrst few injections (Fig. 7A,
inlet). Increasing the heparin/peptide ratio at a molar ratio of 0.8
and higher led to a less turbid solution. In the peptide-into-heparin
titration experiment, PACAP solution showed a signiﬁcant increase
of turbidity at a molar ratio of npeptide/heparin = 2 and higher
(Fig. 7B). Interestingly, D4- and D6-PACAP displayed a somewhat
similar capacity to that of PACAP to form large particles in the hep-
arin-into-peptide titration experiment. In the peptide-into-heparin
titration, the increase of turbidity at 400 nm was faster in the case
of PACAP. Nonetheless, it is very unlikely that the slight variation in
heparin clustering in vitro observed for D4-PACAP and D6-PACAP
underlies the pronounced difference in the cellular uptake of these
peptides by CHO-K1 cells. Overall, these data indicate that the
uptake efﬁcacy of PACAP does not necessary correlate to its
in vitro binding to sulfated GAGs and/or GAGs clustering capacity.
Instead, we showed that the conformational transition of a natively
disordered cationic CPP is crucial for GAGs-mediated
internalization.
4. Discussion
Cell surface GAGs were shown to interact with relatively high
afﬁnity with polycationic peptides [33–36] and to contribute
signiﬁcantly to the cellular uptake of CPPs [12–15]. It has been
originally hypothesized that the contribution of GAGs in uptake
is primarily related to the adsorption of CPPs to the outer leaﬂet
of the plasma membrane through electrostatic interactions [37].
Over the last decade, several reports have instead proposed that
the capacity of cationic CPPs to cluster GAGs can be ascribed to
their cell penetrating efﬁcacy [14,15,32]. For instance, it was
shown that the internalization efﬁciency of penetratin derivatives
correlates directly with their ability to cluster heparin in vitro
[14]. On the other hand, it has been recently shown that the
cellular uptake efﬁcacy of CPPs derived from the human protein
lactoferrin (hLF) does not correlate with the propensity of hLF pep-
tides to cluster HS in vitro [38]. Instead, the authors found a strong
Fig. 5. Inhibition of heparin-induced conformational transition of PACAP with double-D substitutions. (A, B) Circular dichroism spectra of (A) [D-Ser11, D-Arg12, D-Leu23, D-
Ala24]PACAP (D4-PACAP) and (B) [D-Ser11, D-Arg12, D-Leu23, D-Ala24, D-Gln33, D-Arg34]PACAP (D6-PACAP) in absence or in presence of increasing concentrations of heparin
(3.125–50 lM). Buffer in all experiments is 20 mM phosphate, 100 mM NaF, pH 7.4, temperature is 25 C and peptide concentration is 50 lM. (C) Heparin afﬁnity
chromatography of PACAP and its derivatives. Superimposed chromatograms of PACAP (red), D4-PACAP (black) and D6-PACAP (green) elution with increasing NaCl
concentration on a Sepharose heparin column connected to a FPLC Aktapure system. Injection of 250 lg of peptides in phosphate buffer (20 mM, pH 7.4) and the ﬂow rate is
0.5 ml/min.
Fig. 6. Role of PACAP conformational conversion in GAGs-mediated cellular uptake. (A) Representative ﬂow cytometry histograms showing cellular uptake of 1 lM D4-
PACAP38 (black), D6-PACAP (green) or PACAP (red) in CHO-K1 cells. (B) Cellular uptake of PACAP38 and derivatives by CHO-K1 cells. (C) Representative ﬂow cytometry
histograms showing cellular uptake of 1 lM D4-PACAP (black), D6-PACAP (green) or PACAP (red) in CHO-pgs-A-745 cells. (D) Cellular uptake of PACAP and derivatives by
CHO-pgs-A-745 cells. (B, D) Data represent the relative mean ﬂuorescence intensity (±S.E.M.) of gated cells from at least 3 individual experiments and results are expressed as
a percentage of the median ﬂuorescence for PACAP used at the same concentration. (A–D) Cells were incubated for 1 h at 37 C in 5% CO2 with ﬂuorescein-peptides, washed
twice with HBSS, treated with 100 lg/ml heparin for 5 min, detached by trypsin treatment, washed by centrifugation and resuspended in ice-cold sorting buffer before
performing ﬂow cytometry analysis.
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stoichiometry of binding to HS of hLF peptide analogs [38]. Thus,
although the contribution of cell surface GAGs in the uptake of cat-
ionic CPPs is well-recognized, the molecular mechanisms by which
proteoglycans facilitate internalization remain unclear [11].
Moreover, even if some studies have reported that the binding of
cationic peptides to sulfated GAGs induces the formation of an a-
helix [28,29], the role(s) of this conformational shift in GAGs-
mediated cellular uptake has not been investigated so far.
Herein, we focused on the mechanism of cellular uptake of
PACAP in the context of cell surface GAGs. As previously reported
for other cationic CPPs [11–15,29], we showed here that GAGs play
a pivotal role in the internalization of PACAP. It was originallyassumed that the chirality and/or secondary structure of cationic
CPPs did not play a pivotal role in their uptake efﬁcacy [13].
Instead, the number of positively charged residues and their linear
disposition were considered as the key factors for efﬁcient
internalization. However, it was recently reported that the uptake
efﬁciency of a CPP derived from the hLF protein is dependent on its
conformation [39] and that L-nona-arginine peptide is internalized
more efﬁciently than its all-D-counterpart [40]. As we observed
that PACAP readily adopts an a-helix in presence of heparin, we
sought to investigate the role(s) of this heparin-induced conforma-
tional conversion in cellular uptake by destabilizing PACAP helical
structure. D,D-analogs bound heparin with a relative afﬁnity simi-
lar to that observed for PACAP and both peptides were efﬁcient to
Fig. 7. Light scattering showing heparin clustering by PACAP38 and its D,D-
derivatives. (A) Titration of heparin into PACAP (), D4-PACAP (h) or D6-PACAP ()
monitored by turbidity at 400 nm. Each peak corresponds to the injection of 1.25 l
of a 100 lM heparin solution into a 1 ml 50 lM peptide solution. Inset: emphasis on
the initial phase of the titration assay. (B) Titration of PACAP (), D4-PACAP (h) and
D6-PACAP () into heparin monitored by turbidity at 400 nm. Each peak
corresponds to the injection of 12.5 ll of a 200 lM peptide solution into a 1 ml
10 lM heparin solution. Data are expressed as a function of the heparin/peptide
molar ratio (A) or peptide/heparin molar ratio (B). (A, B) All experiments were
performed in 20 mM phosphate, 100 mM NaCl, pH 7.4.
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taken up by CHO-K1 cells. In sharp contrast, in GAGs-deﬁcient
cells, the levels of uptake of D,D-analogs were around 80% of that
of PACAP. This indicates that this conformational conversion is
essential in GAGs-dependent internalization whereas in GAGs-
independent uptake, the formation of a helical secondary structure
is not an absolute prerequisite for cellular uptake. To the best of
our knowledge, this is the ﬁrst report describing a key implication
of conformational conversion of a cationic CPP in GAGs-mediated
endocytosis. It has been recently shown that the stoichiometry of
peptide-HS binding is a key determinant in the uptake efﬁciency
of CPPs [38]. Unfortunately, because of the prompt aggregation in
the initial phase of PACAP-into-heparin and heparin-into-PACAP
titrations, we were unable to determine the binding stoichiometry
by ITC. Nevertheless, it is hypothesized that the conformational
shift of PACAP modiﬁes the stoichiometry of peptide-GAGs bind-
ing, resulting in a change in internalization level, an avenue that
should be further investigated. Besides, formation of an a-helix
triggers the spatial gathering of Arg and Lys side chains and the
formation of clusters of positive charges that might tighten
GAGs–peptide interactions.
Overall, this study emphasizes the promoting roles of cell sur-
face proteoglycans in the endocytosis of cationic CPPs and sheds
light on the molecular basis of the high cell penetrating capacity
of PACAP. Besides, we demonstrated that the uptake efﬁciency of
a given cationic CPP does not necessarily correlate to its in vitro
binding to sulfated GAGs and/or to its in vitro ability to cluster
GAGs. Instead, this report describes that the adoption of an a-helix
is a crucial step for GAGs-mediated endocytosis of a cationic CPP.
This observation will support the development of CPPs since it is
not only GAGs binding/clustering but also peptide conformation
that drives the extent of internalization.Author contribution
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